U.S. to see higher generic drug prices thanks to tariffs, CEO of leading India pharma firm warns
CNBC Top · 2026-07-24
TOPIC
Biotech & FDA News
FDA drug approvals, clinical trial results, and biotech stock-moving news.
Related Tickers
$LLY · Eli Lilly$NVO · Novo Nordisk$JNJ · Johnson & Johnson$PFE · Pfizer$MRK · Merck$ABBV · AbbVie$UNH · UnitedHealthLatest Coverage
FDA panel supports access to peptides over objections by scientists at US regulator - Financial Times
Financial Times · 2026-07-23
This Biotech Company Has Spent Nearly 3 Years in FDA Limbo - inkl
inkl · 2026-07-17
AI Giants Pile Into Pharma: Google, OpenAI, Anthropic Diverge on Strategy, but Big Pharma May Be the Ultimate Winner - finance.biggo.com
finance.biggo.com · 2026-07-14
Apnimed files for IPO as FDA reviews its sleep apnea drug - Endpoints News
Endpoints News · 2026-07-13
Silo Pharma stock tumbles 22% on dilutive private placement
Investing.com · 2026-07-10
AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse
CNBC Top · 2026-07-09
Form S-1 Aeon Biopharma Inc For: 8 July
Investing.com · 2026-07-08
Oric Pharmaceuticals director Heyman sells $3,600 in stock
Investing.com · 2026-07-08
FDA halts release of new drug rejection letters while working to formalize policy - Fierce Biotech
Fierce Biotech · 2026-07-08
Is Regeneron Pharmaceuticals, Inc. (REGN) Stock Still a Biotech Leader After Analyst Price Target Cut?
Insider Monkey · 2026-07-08
Is Ionis Pharmaceuticals, Inc. (IONS) Stock a Buy After Tryngolza’s FDA Approval?
Insider Monkey · 2026-07-08
Is Crinetics Pharmaceuticals, Inc. (CRNX) Stock a Buying Opportunity After a 44% Pullback?
Insider Monkey · 2026-07-08
A New Look At Legend Biotech: Plenty Of Upside For Carvykti
Seeking Alpha · 2026-07-08
Biotech Euphoria Driven By Fundamentals
Seeking Alpha · 2026-07-08
Why This Biotechnology Stock is a Top Pick at TD Cowen Right Now
Investing.com · 2026-07-08
Seres Therapeutics, Inc. (MCRB) Discusses Promising SER-155 Clinical Trial Results for Immune Checkpoint Inhibitor Related Andropilatis - Slideshow
Seeking Alpha · 2026-07-08
FDA grants breakthrough designation to enpatoran for lupus
Investing.com · 2026-07-08
UroGen receives FDA clearance for bladder cancer trial
Investing.com · 2026-07-08
Guggenheim raises Vera Therapeutics stock price target on FDA approval
Investing.com · 2026-07-08
FDA accepts Immunome NDA for desmoid tumor treatment varegacestat
Investing.com · 2026-07-08
OKYO Pharma receives FDA feedback on phase 3 neuropathic pain trial
Investing.com · 2026-07-08
Seres Therapeutics, Inc. (MCRB) Discusses Promising SER-155 Clinical Trial Results for Immune Checkpoint Inhibitor Related Andropilatis Transcript
Seeking Alpha · 2026-07-08
Kura Oncology: A Menin Inhibitor Launch With More Than One Way To Win
Seeking Alpha · 2026-07-08
Why is Sichuan Kelun Biotech stock sliding today?
Investing.com · 2026-07-08
China’s biotech firms challenge US with rapidly developing RAS-targeted cancer therapies
SCMP Business · 2026-07-08
Tempus AI (TEM) Launches Next-Gen Agentic Platform to Accelerate Oncology Research
Insider Monkey · 2026-07-08
World's First Fully Robotic Pharmacy Automates Prescription Dispensing
Zero Hedge · 2026-07-08
Form 4 Eton Pharmaceuticals Inc For: 7 July
Investing.com · 2026-07-07
Form 144 IONIS PHARMACEUTICALS INC For: 7 July
Investing.com · 2026-07-07
Opaleye management sells $4.77m Eton Pharmaceuticals (ETON) stock
Investing.com · 2026-07-07
Compass Pathways Phase 3 COMP006 Data Review
Seeking Alpha · 2026-07-07
ARS Pharmaceuticals stock falls as CEO Lowenthal steps down
Investing.com · 2026-07-07
Crinetics Pharmaceuticals director sells $120,000 in stock
Investing.com · 2026-07-07
Biocryst Pharmaceuticals stock hits 52-week high at 10.94 USD
Investing.com · 2026-07-07
Form 144 ROCKET PHARMACEUTICALS For: 7 July
Investing.com · 2026-07-07
Vera Therapeutics, Inc. (VERA) Discusses Accelerated FDA Approval of TRUTAKNA for IgA Nephropathy Transcript
Seeking Alpha · 2026-07-07
COMPASS Pathways plc (CMPS) Discusses Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile in Depression Transcript
Seeking Alpha · 2026-07-07
US FDA approves Vera's kidney disease drug - Reuters
Reuters · 2026-07-07
FDA approves Vera Therapeutics kidney disease treatment - STAT
STAT · 2026-07-07
Frequently Asked Questions
What is Biotech & FDA?
FDA drug approvals, clinical trial results, and biotech stock-moving news.
Which stocks are in the Biotech & FDA space?
Commonly tracked tickers include LLY, NVO, JNJ, PFE, MRK. Catalayer maintains curated ticker pages with live news at /stocks/ for each.
Why does Biotech & FDA matter for investors?
Biotech & FDA influences market sentiment, sector rotation, and individual stock valuations. Catalayer’s Market Intelligence tier adds AI-powered event classification so you can see which stories are likely to move prices.
How can I monitor Biotech & FDA in real time?
Create a custom keyword monitor on Catalayer with any of these terms: fda, biotech, clinical trial, drug approval, pharma, gene therapy. Free accounts get 1 monitor; Plus ($29/mo) unlocks 5 simultaneous monitors with boolean rules.
Monitor Biotech & FDA News live
Get alerted whenever news matches this topic.